Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Decades ago, blue lights helped shoppers scope out sales. Today they’re helping urologists scope out cells – specifically those of non-muscle-invasive bladder cancer. UW Medicine urologists with ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
Doctors do not typically use a cystoscopy to detect or diagnose prostate cancer, but it may reveal abnormalities in the prostate or signs of cancer in the bladder and other areas of the urinary tract.
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
New urine test can improve accuracy for early detection of bladder cancer in patients with hematuria
A streamlined urine DNA test more accurately detects primary bladder cancer, reducing the need for more invasive cystoscopy, reports The Journal of Molecular Diagnostics Lead investigator Sungwhan An, ...
Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.
We used four deep learning models (ConvNeXt, PlexusNet, MobileNet, and SwinTransformer) covering a variety of model complexity and efficacy. We trained these models on a previously published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results